logo.jpg
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
14 mars 2024 07h00 HE | AC Immune SA
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2ACI-7104.056 VacSYn Phase 2 trial in...
logo.jpg
AC Immune Announces Upcoming Presentations at AD/PD™ 2024
22 févr. 2024 07h00 HE | AC Immune SA
AC Immune Announces Upcoming Presentations at AD/PD™ 2024 Multiple presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2024)Andrea Pfeifer, Ph.D., CEO to...
logo.jpg
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
03 janv. 2024 08h10 HE | AC Immune SA
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases ABATE Phase 1b/2 AD trial of ACI-24.060 completed enrollment of cohorts 1 and 2 and...
NRG Therapeutics - new.jpg.png
NRG Therapeutics Awarded Second $500K Grant from The Michael J. Fox Foundation to Further Progress Parkinson’s Programme
22 févr. 2023 04h00 HE | NRG Therapeutics Limited
STEVENAGE, United Kingdom, Feb. 22, 2023 (GLOBE NEWSWIRE) -- NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has been...
IGC Logo.jpg
IGC to Present at the RHK 2022 Disruptive Growth Conference
30 nov. 2022 11h19 HE | INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc (NYSE American: IGC) (“IGC” or the “Company”) today announced that Ram Mukunda, Chief Executive Officer, will be...
LOGO.png
IMAC Holdings to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
05 janv. 2021 09h00 HE | IMAC Holdings, Inc.
BRENTWOOD, Tenn., Jan. 05, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
wuhan-english-1-e1537022922195.png
CORRECTING and REPLACING – Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
22 mai 2020 10h43 HE | Wuhan General Group, Inc.
AUSTIN, Texas, May 22, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by SmallCapVoice.com, Inc. and Wuhan General Group, Inc. (OTC PINK: WUHN), please note that...
wuhan-english-1-e1537022922195.png
Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
22 mai 2020 08h00 HE | Wuhan General Group, Inc.
AUSTIN, Texas, May 22, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Wuhan General Group, Inc. (OTC PINK: WUHN) (the "Company" and "Wuhan"), announced today that a new audio interview...
Naboso Technology™ Proprioceptive Mat and Insoles
Naboso™ Technology Expands Product Line to include the First Commercially Available Textured Insoles and Mats designed to Improve Posture, Balance and Strength through Stimulation of the Feet
22 janv. 2019 09h00 HE | Naboso Technology
NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Naboso™ Technology, a leading proprioceptive insole and mat company dedicated to revolutionizing the neurological rehabilitation, human performance and...
Digitsole Zhor-Tech
CES: Smart Footwear brand Digitsole in partnership with the company Zhor-Tech revolutionize medical diagnostics with M-Cube technology
09 janv. 2019 16h34 HE | Zhor-Tech
Nancy , France, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Digitsole, creating the future of footwear by introducing electronics and software into footwear products, is revolutionizing the medical...